Hemolytic Uremic Syndrome
7
0
0
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
28.6%
2 terminated out of 7 trials
50.0%
-36.5% vs benchmark
29%
2 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy"
Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
The Plasma Large-Volume Exchange RCT
Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis
Rituximab in Patients With Relapsed or Refractory TTP-HUS